Stay updated on Influenza Virus Challenge Trial for Monoclonal Antibody
Sign up to get notified when there's something new on the Influenza Virus Challenge Trial for Monoclonal Antibody page.

Latest updates to the Influenza Virus Challenge Trial for Monoclonal Antibody page
- Check6 days agoChange DetectedAdded the revision notice 'Revision: v3.3.3' and removed the 'HHS Vulnerability Disclosure' link along with the previous 'Revision: v3.3.2'; these are administrative site updates rather than study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedThe additions now explicitly state that PubMed publications are automatically filled from PubMed and include the revision tag v3.3.2. The deletions now use updated wording indicating PubMed publications originate from PubMed and include the revision tag v3.2.0.SummaryDifference0.1%

- Check42 days agoChange DetectedThe government funding status notice on the page has been removed. This notice previously informed users about potential delays and information updates related to funding.SummaryDifference0.4%

- Check56 days agoChange DetectedAdded London, United Kingdom as a study location and updated the recruitment status.SummaryDifference0.3%

- Check85 days agoChange DetectedThe page now includes a government-funding and operating-status notice and marks a new version (v3.2.0), replacing the previous v3.1.0.SummaryDifference4%

- Check92 days agoChange Detected- Added new chemical categories and contact numbers; updated revision to v3.1.0. - Removed several drug-safety and saline-related terms and older revision v3.0.2.SummaryDifference1%

Stay in the know with updates to Influenza Virus Challenge Trial for Monoclonal Antibody
Enter your email address, and we'll notify you when there's something new on the Influenza Virus Challenge Trial for Monoclonal Antibody page.